Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$636M
| $3.32M | ﹤0.01% |
63,520
+36,071
| +131% | +$1.98M |
|
|
ROCC
4477
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $3.31M | ﹤0.01% |
+100,845
| New | +$3.8M |
|
|
ATCO
4478
PUT
DELISTED
Atlas Corp.
ATCO
| $3.31M | ﹤0.01% |
309,500
+205,500
| +198% | +$2.58M |
|
4479
PUT
iShares S&P 500 Value ETF
IVE
$50.3B
| $3.31M | ﹤0.01% |
24,100
+18,500
| +330% | +$2.73M |
|
4480
Ingles Markets
IMKTA
$1.65B
| $3.31M | ﹤0.01% |
38,138
+12,664
| +50% | +$1.15M |
|
|
PDS
4481
Precision Drilling
PDS
$1.09B
| $3.31M | ﹤0.01% |
51,641
+13,218
| +34% | +$959K |
|
|
CCV
4482
DELISTED
Churchill Capital Corp V
CCV
| $3.3M | ﹤0.01% |
336,115
-1,409,989
| -81% | -$13.9M |
|
|
CBD
4483
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $3.3M | ﹤0.01% |
1,065,594
+212,080
| +25% | +$900K |
|
4484
CALL
Editas Medicine
EDIT
$433M
| $3.3M | ﹤0.01% |
279,100
-47,900
| -15% | -$642K |
|
4485
Denison Mines
DNN
$2.92B
| $3.3M | ﹤0.01% |
3,391,213
-31,948
| -0.9% | -$41K |
|
4486
Bunge Global
BG
$21.8B
| $3.3M | ﹤0.01% |
36,355
-679,770
| -95% | -$75.4M |
|
4487
CALL
Main Street Capital
MAIN
$5.5B
| $3.29M | ﹤0.01% |
85,500
+43,500
| +104% | +$1.7M |
|
4488
Invesco Water Resources ETF
PHO
$2.05B
| $3.29M | ﹤0.01% |
71,254
+28,311
| +66% | +$1.38M |
|
4489
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$184M
| $3.29M | ﹤0.01% |
+106,000
| New | +$3.74M |
|
4490
PUT
iShares Latin America 40 ETF
ILF
$3.71B
| $3.28M | ﹤0.01% |
+145,700
| New | +$3.88M |
|
4491
CALL
Enanta Pharmaceuticals
ENTA
$383M
| $3.28M | ﹤0.01% |
69,400
+56,500
| +438% | +$3.07M |
|
4492
CALL
Upbound Group
UPBD
$1.14B
| $3.28M | ﹤0.01% |
168,700
+4,400
| +3% | +$110K |
|
4493
CALL
iShares MSCI Germany ETF
EWG
$1.68B
| $3.28M | ﹤0.01% |
142,500
-590,900
| -81% | -$15.4M |
|
4494
CALL
uniQure
QURE
$3.37B
| $3.28M | ﹤0.01% |
175,800
-14,500
| -8% | -$231K |
|
4495
PUT
iShares Russell 1000 Value ETF
IWD
$84.2B
| $3.28M | ﹤0.01% |
22,600
-26,700
| -54% | -$4.18M |
|
4496
CALL
Virtu Financial
VIRT
$5.3B
| $3.27M | ﹤0.01% |
139,900
-14,200
| -9% | -$406K |
|
4497
PUT
Direxion Daily Technology Bull 3x ETF
TECL
$6.39B
| $3.27M | ﹤0.01% |
116,600
-86,500
| -43% | -$3.44M |
|
4498
Alarm.com
ALRM
$2.73B
| $3.27M | ﹤0.01% |
52,832
+42,792
| +426% | +$2.63M |
|
4499
PUT
SentinelOne
S
$7.92B
| $3.27M | ﹤0.01% |
140,000
-36,800
| -21% | -$1.03M |
|
4500
CALL
Kymera Therapeutics
KYMR
$9.76B
| $3.27M | ﹤0.01% |
165,800
+144,800
| +690% | +$3.38M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.